Raia Drogasil SA Stock Sao Paulo
Stocks
DROG3
BRDROGACNOR1
Drug Retailers
OTC Markets Traded|
End-of-day quote
Sao Paulo
|
||
| - BRL | - |
|
| 11-05 | Raia Drogasil S.A., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-04 | Raia Drogasil S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 24.93B 4.44B 4.01B 3.7B 3.35B 6.32B 417B 6.51B 44.44B 17.66B 223B 16.65B 16.29B 710B | P/E 2026 * |
16.8x | P/E 2027 * | 12.6x |
|---|---|---|---|---|---|
| Enterprise Value | 33.86B 6.02B 5.45B 5.03B 4.55B 8.59B 566B 8.84B 60.35B 23.98B 303B 22.61B 22.12B 964B | EV / Sales 2026 * |
0.75x | EV / Sales 2027 * | 0.68x |
| Free-Float |
73.04% | Yield 2026 * |
2.41% | Yield 2027 * | 2.94% |
Last Transcript: Raia Drogasil SA
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/01/2025 | |
| Director of Finance/CFO | 63 | 29/04/2013 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 50 | 01/01/2025 | |
| Director/Board Member | - | - | |
Gilberto Lerio
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | -4.30% | -35.81% | +8.66% | 17.06B | |
| -0.10% | +5.59% | -9.28% | +14.97% | 6.97B | |
| +1.85% | +3.35% | -7.10% | +5.16% | 6.61B | |
| -0.85% | -6.45% | -50.85% | -39.71% | 6.17B | |
| -22.29% | -2.93% | -36.34% | -45.63% | 4.6B | |
| +1.35% | -6.86% | +0.04% | -21.28% | 4.45B | |
| +0.55% | -2.17% | +4.43% | -20.20% | 3.44B | |
| +0.74% | +2.42% | -11.81% | -27.40% | 3.28B | |
| -1.20% | +23.85% | +56.51% | - | 3.17B | |
| Average | -2.16% | +1.97% | -10.02% | -15.68% | 6B | |
| Weighted average by Cap. | -1.42% | +2.43% | -18.80% | -8.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 44.99B 8B 7.24B 6.68B 6.05B 11.41B 752B 11.75B 80.2B 31.87B 402B 30.04B 29.4B 1,280B | 51.05B 9.08B 8.21B 7.58B 6.86B 12.95B 854B 13.34B 91B 36.16B 456B 34.09B 33.36B 1,453B |
| Net income | 1.49B 266M 240M 222M 201M 379M 25B 390M 2.66B 1.06B 13.36B 998M 977M 42.53B | 1.99B 353M 320M 295M 267M 504M 33.23B 519M 3.54B 1.41B 17.76B 1.33B 1.3B 56.54B |
| Net Debt | 8.92B 1.59B 1.44B 1.33B 1.2B 2.26B 149B 2.33B 15.9B 6.32B 79.78B 5.96B 5.83B 254B | 9.62B 1.71B 1.55B 1.43B 1.29B 2.44B 161B 2.51B 17.15B 6.82B 86.03B 6.42B 6.29B 274B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RADL3 Stock
- DROG3 Stock
Select your edition
All financial news and data tailored to specific country editions
